CalciMedica (CALC) Operating Expenses (2019 - 2026)
CalciMedica's (CALC) quarterly Operating Expenses came in at $5.6 million in Q1 2026, down 13.64% YoY from $6.5 million in Q1 2025, and up 28.57% on a QoQ basis from $4.4 million in Q4 2025.
CalciMedica (CALC) Operating Expenses (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Operating Expenses data on file, last reported at $5.6 million in Q1 2026.
- Quarterly Operating Expenses fell 13.64% year-over-year to $5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.2 million (down 10.91% YoY) and the FY2025 annual result came in at $23.1 million, down 4.56% from the prior year.
- Operating Expenses rose to $5.6 million in Q1 2026, from $4.4 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $22.3 million in Q1 2023 to a low of $3.1 million in Q4 2022.
- A 5-year average of $6.2 million and a median of $5.6 million in 2025 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2023 — Operating Expenses jumped 430.52% — and 2024, when it sank 74.19%.
- Tracing CALC's Operating Expenses over 5 years: stood at $3.1 million in 2022, then jumped by 39.1% to $4.3 million in 2023, then jumped by 42.9% to $6.2 million in 2024, then fell by 29.29% to $4.4 million in 2025, then climbed by 28.57% to $5.6 million in 2026.
- The last three Operating Expenses figures came in at $5.6 million (Q1 2026), $4.4 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | CalciMedica | 9.93 Mn | -8.69 Mn | - | 4.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.01 Mn |
| Mar 31, 2026 | 5.61 Mn |
| Dec 31, 2025 | 4.36 Mn |
| Sep 30, 2025 | 5.62 Mn |
| Jun 30, 2025 | 6.62 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Dec 31, 2024 | 6.17 Mn |
| Sep 30, 2024 | 5.74 Mn |
| Jun 30, 2024 | 6.53 Mn |
| Mar 31, 2024 | 5.77 Mn |
| Dec 31, 2023 | 4.32 Mn |
| Sep 30, 2023 | 4.83 Mn |
| Jun 30, 2023 | 6.58 Mn |
| Mar 31, 2023 | 22.34 Mn |
| Dec 31, 2022 | 3.11 Mn |
| Sep 30, 2022 | 3.29 Mn |
| Jun 30, 2022 | 3.59 Mn |
| Mar 31, 2022 | 4.21 Mn |
| Dec 31, 2021 | 8.70 Mn |
| Sep 30, 2021 | 8.02 Mn |